Macular Edema Incidence/Severity Reduction With Nevanac
| Status: | Archived |
|---|---|
| Conditions: | Ocular, Diabetes |
| Therapuetic Areas: | Endocrinology, Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2009 |
The purpose of this study is to determine the safety and efficacy of Nevanac for the
prevention of macular edema in patients with diabetic retinopathy within 90 days following
cataract surgery.
We found this trial at
1
site
Alcon Call Center Alcon is helping people see the world better through advanced surgical, pharmaceutical...
Click here to add this to my saved trials
